Talía Velasco-Hernández

19PUBLICATIONS
164CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 06, 2026
A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist.

|Aug 06, 2025
A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias.

Lorena Pérez-Amill, Mercedes Armand-Ugón, Maria Val-Casals

|Jul 03, 2025
CAR-T cell therapy for cancer: current challenges and future directions.

Inés Zugasti, Lady Espinosa-Aroca, Klaudyna Fidyt

|Mar 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Aïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti

|Aug 21, 2024
RNA sequestration in P-bodies sustains myeloid leukaemia.

Srikanth Kodali, Ludovica Proietti, Gemma Valcarcel

|Aug 02, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

Belén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles

Pageof 4

Frequent Collaborators

5 joint publications

Pablo Menéndez

5 joint publications

Oscar Molina

4 joint publications

Narcís Fernández-Fuentes

4 joint publications

Meritxell Vinyoles